Li D - Search Results

1

Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study.

Liang C, Li D, Liang Y, Xie Y, Lin N, Guan H, Hu W, Guan Y, Liang Y. Liang C, et al. Among authors: li d. Ann Surg Oncol. 2024 Jul;31(7):4594-4604. doi: 10.1245/s10434-024-15327-4. Epub 2024 Apr 30. Ann Surg Oncol. 2024. PMID: 38689172

2

Time-varying pattern of recurrence risk for localized melanoma in China.

Wen X, Li D, Zhao J, Li J, Yang T, Ding Y, Peng R, Zhu B, Huang F, Zhang X. Wen X, et al. Among authors: li d, li j. World J Surg Oncol. 2020 Jan 4;18(1):6. doi: 10.1186/s12957-019-1775-5. World J Surg Oncol. 2020. PMID: 31901239 Free PMC article.

3

Whole-exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets.

Li J, Chen C, Liu W, Liu S, Hu W, Gao X, Liu G, Li D, Ding Y, Wen X, Zhang X, Hou Y, Zhang X, Li B, Zhang X, Zhang X. Li J, et al. Among authors: li d, li b. Clin Transl Med. 2021 Dec;11(12):e640. doi: 10.1002/ctm2.640. Clin Transl Med. 2021. PMID: 34923763 Free PMC article. No abstract available.

4

[No title available]

[No authors listed] [No authors listed] PMID: 38773040

5

Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence.

Zhen J, Chen L, Wang H, Li D, Lai M, Ding Y, Yang Y, Li J, Wen X, Cai L, Zhang X. Zhen J, et al. Among authors: li d, li j. J Neurooncol. 2024 Dec;170(3):665-673. doi: 10.1007/s11060-024-04843-8. Epub 2024 Oct 18. J Neurooncol. 2024. PMID: 39422814

6

The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series.

Wen X, Ding Y, Li J, Zhao J, Peng R, Li D, Zhu B, Wang Y, Zhang X, Zhang X. Wen X, et al. Among authors: li d, li j. Cancer Immunol Immunother. 2017 Sep;66(9):1153-1162. doi: 10.1007/s00262-017-1989-8. Epub 2017 Apr 25. Cancer Immunol Immunother. 2017. PMID: 28444424 Free PMC article.

7

A prognostic model for resectable acral melanoma patients on the basis of preoperative inflammatory markers.

Wang Y, Wen XZ, Ba HJ, Li DD, Ding Y, Wang KF, Li JJ, Zhang XS. Wang Y, et al. Melanoma Res. 2017 Oct;27(5):469-476. doi: 10.1097/CMR.0000000000000365. Melanoma Res. 2017. PMID: 28574975

8

Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study.

Liu X, Li JJ, Ding Y, Li DD, Wen XZ, Weng DS, Wang JH, Jiang H, Zhang XS. Liu X, et al. Front Oncol. 2021 Apr 1;11:582676. doi: 10.3389/fonc.2021.582676. eCollection 2021. Front Oncol. 2021. PMID: 33868987 Free PMC article.

9

Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis.

Li J, Wang J, Li D, Wen X, Ding Y, Liu X, Jiang H, Huang F, Zhang X. Li J, et al. Among authors: li d. Dermatol Ther. 2021 Sep;34(5):e15067. doi: 10.1111/dth.15067. Epub 2021 Jul 29. Dermatol Ther. 2021. PMID: 34302318

10

Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients.

Wang J, Jiang H, Huang F, Li D, Wen X, Ding Q, Ding Y, Zhang X, Li J. Wang J, et al. Among authors: li d, li j. J Cancer Res Clin Oncol. 2023 Feb;149(2):701-708. doi: 10.1007/s00432-022-04377-4. Epub 2022 Dec 1. J Cancer Res Clin Oncol. 2023. PMID: 36454283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,720 results

Search Page

Filters